The Enterprise Europe Network helps companies source EU funding and project partners for lifesaving research. Swedish firm Biovica and British company Sentinel Oncology linked up through the Network to develop a potential treatment for a rare blood cancer, acute myleloid leukaemia. The partnership has received more than €500,000 in funding from the EU’s Eurostars programme. Stuart Travers, Sentinel Oncology chief operating officer, says: "If all goes well, the treatment should have a pretty clear path to the market." Read the full story